Using Game-based Exercise to Improve Balance in Cancer Patients
Completed · Phase 2
Conditions studied: Chemotherapy Induced Peripheral Neuropathy, Cancer
In brief
Cancer patients with chemotherapy-induced peripheral neuropathy (CIPN) have deficits in sensory and motor skills leading to inappropriate proprioceptive feedback, impaired postural control and high fall risk. This study will investigate the acceptability and effect of an interactive motor adaptation balance training program based on wearable sensors for improving balance in older cancer patients with CIPN. Cancer patients with confirmed CIPN will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 6-week balance training program twice per week in either their home or in clinic (based on subject preference) under the supervision of a qualified research staff member. This intervention includes interactive game-based balance training including repetitive weight shifting and virtual obstacle crossing tasks. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, and number of falls will be compared pre- and post-intervention, as well as 3 and 6 month post intervention. Investigators hypothesize that patients receiving sensor-based exercise training will benefit more compared to group receiving conventional non-technology home-based training in terms of improving functional performance and reducing falls.
Key facts
- Study ID
- NCT02773329
- Run by
- Baylor College of Medicine
- People needed
- 35
- Starts
- 2016-05-01
- Expected to finish
- 2019-05-01
- Last updated by the study team
- 2019-06-26
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Cancer patients
- Men or women aged 55 years or older
- Patients undergoing neurotoxic chemotherapy (agents including platinums, vinca alkaloids, taxanes, proteasome inhibitors and interferons)
- Confirmed peripheral neuropathy (VPT>25) will be eligible to participate
You may not qualify if…
- Subjects will be excluded if they have undergone surgery in the last 6-8 weeks
- Have Parkinson's Disease
- Stroke patients
- Dementia patients
- Have an active foot ulcer
- Have an active infection
- Lower extremity major amputation
- Patient is taking medications unrelated to cancer treatment that may affect balance and gait
- Patient has other medical conditions that may affect their balance and gait
- Patient is unable to ambulate without assistance.
Where it is running
- Baylor College of Medicine — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.